Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home2/firstmedlabs/public_html/wp-includes/functions.php on line 6170

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the quadmenu domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home2/firstmedlabs/public_html/wp-includes/functions.php on line 6170
MD HeartPro | First Medical Labs | Official Site | Reference Laboratory

MDHeartPro

Delivering rapid, reliable, and meaningful results. Providing impactful, individualized molecular diagnostics solutions.

Get to the Heart of Your Patient’s Risk with MDHeartPro

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, set diam volupta. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est lorem ipsum dolor sit amet. Lorem.

 

Inflammation Profile

  • The PLAC test is the only blood test that measures Lp-PLA2: a vascular specific inflammatory marker critical in the formation of rupture-prone plaque.
  • The only FDA-cleared blood test for stroke
  • hs-CRP: Stroke risk 11 times greater if both Lp-PLA2 and hs-CRP “high risk.”

Advanced Risk Markers

  • sd-LDL: Increases MI risk 3z
  • Lipoprotein (a) “widow maker gene”: One in five people are genetically predisposed to have a dangerous level of this protein. 10x more predictive of premature heart disease than LDL cholesterol.
  • Apo B: Apo A-1 Ratio is an efective predictor of coronary heart disease risk in overweight and obesity. It is a powerful marker of risk for future cardiovascular disease.
50% of heart attacks occur in patients with normal cholesterol.
60% of patients who have a cardiac event have normal lipid levels.